Clinical trials
Phase 2/3 Carcinoma, Non-Small-Cell Lung trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Completed | 5 |
| Terminated | 5 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| SWOG Cancer Research Network | 3 |
| AbbVie | 2 |
| Hoffmann-La Roche | 2 |
| National Cancer Institute (NCI) | 2 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Clovis Oncology, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Eikon Therapeutics | 1 |
| Genta Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 25 |
| Lung Neoplasms | 11 |
| Adenocarcinoma of Lung | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
| Adenocarcinoma, Bronchiolo-Alveolar | 1 |
| Anorexia | 1 |
| Carcinoma, Squamous Cell | 1 |
| Esophageal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.